Immunotherapy with a HER2-Targeting Listeria Induces HER2-Specific Immunity and Demonstrates Potential Therapeutic Effects in a Phase I Trial in Canine Osteosarcoma.
Clin Cancer Res. 2016 Sep 1;22(17):4380-90. doi: 10.1158/1078-0432.CCR-16-0088. Epub 2016 Mar 18.
Clin Cancer Res. 2016.
PMID: 26994144
Free article.
Clinical Trial.